Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means

A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.

Source: Decrypt
https://decrypt.co/375968/moderna-stock-doubles-cancer-vaccine

What's your take — bullish or bearish? Discuss below.